Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.87 - $2.7 $108,276 - $156,335
-57,902 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$2.06 - $3.01 $12,716 - $18,580
6,173 Added 11.93%
57,902 $154,000
Q3 2020

Nov 17, 2020

BUY
$2.85 - $4.1 $3,890 - $5,596
1,365 Added 2.71%
51,729 $147,000
Q2 2020

Aug 17, 2020

BUY
$2.39 - $4.0 $120,369 - $201,456
50,364 New
50,364 $186,000

Others Institutions Holding CDTX

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $837M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.